Pluri Inc.
$ 1.82
0.55%
07 Aug - close price
- Market Cap 19,637,000 USD
- Current Price $ 1.82
- High / Low $ 1.82 / 1.82
- Stock P/E N/A
- Book Value -1.78
- EPS -2.90
- Next Earning Report 2026-09-16
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.51 %
- ROE -10.22 %
- 52 Week High 5.68
- 52 Week Low 1.45
About
Pluri Inc. is an innovative biotechnology company at the forefront of regenerative medicine and immunotherapy, utilizing its proprietary technology platform to develop advanced cell-based therapies for oncology and degenerative conditions. With a robust pipeline of therapeutics aimed at addressing critical unmet medical needs, Pluri actively forms strategic collaborations that bolster its research and development capabilities. Committed to revolutionizing patient care, Pluri is well-positioned to become a significant contributor in the biotechnology landscape, driving growth and delivering impactful healthcare solutions.
Analyst Target Price
$12.00
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-12 | 2025-09-17 | 2025-05-13 | 2025-02-11 | 2024-11-12 | 2024-09-18 | 2024-05-09 | 2024-02-12 | 2023-11-13 | 2023-09-12 | 2023-05-09 | 2023-02-13 |
| Reported EPS | -0.65 | -1 | -0.9365 | -0.5323 | -1.0774 | -1.0593 | -1.0138 | -0.1181 | -0.19 | -0.16 | -0.19 | -1.92 |
| Estimated EPS | -0.74 | -0.73 | None | None | None | None | None | -0.32 | -0.32 | -0.31 | -0.3 | -2.56 |
| Surprise | 0.09 | -0.27 | 0 | 0 | 0 | 0 | 0 | 0.2019 | 0.13 | 0.15 | 0.11 | 0.64 |
| Surprise Percentage | 12.1622% | -36.9863% | None% | None% | None% | None% | None% | 63.0938% | 40.625% | 48.3871% | 36.6667% | 25% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-09-16 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: PLUR
2026-08-08 20:09:50
This article presents a revenue breakdown for Pluri Inc. (NASDAQ: PLUR), highlighting that Israel was the primary contributor to its revenue in the last fiscal year, generating $1.34 million, up from $326,000 the previous year. The data provides insight into the company's financial performance by geographical segment.
2026-08-08 07:09:50
This article provides an earnings forecast for Pluri Inc (PLUR), indicating that no earnings forecast score is currently available, which is below the industry average. Analysts have set a consistent price target of $12.00, suggesting a significant upside. Key financial forecasts include an expected revenue of $655.00K for the next quarter and an anticipated EPS of -$0.66, following a previous EPS of -$0.71.
2026-08-08 02:41:11
This article provides a brief update on Pluri Inc (PLUR) stock news, indicating that more news is expected soon. It also lists key financial data for Pluri Inc, including its stock price, market cap, and P/E TTM. The article appears to be a placeholder for future news and analysis regarding the company.
2026-08-04 06:10:11
This article provides a technical analysis of Pluri Inc (PLUR), highlighting its current price momentum score of 4.86 and its position between resistance at $1.92 and support at $1.32, suggesting suitability for range-bound swing trading. It details various technical indicators like MACD, RSI, and moving averages, most of which indicate a "Sell" or "Neutral" signal for the stock. The analysis concludes with a "Neutral" signal based on moving averages and other technical indicators.
2026-08-01 19:14:04
This article provides a risk assessment for Pluri Inc (PLUR), highlighting its current risk score of 2.15, which ranks 234 out of 384 in the Biotechnology & Medical Research industry. It details the company's beta value of 0.66, indicating underperformance in rising markets and smaller declines in falling markets. The assessment also includes various risk metrics such as volatility, maximum drawdown, and liquidity data over different periods.
2026-08-01 09:09:53
This article provides a revenue breakdown for Pluri Inc. (FWB:4DX), highlighting that the largest contribution to its revenue came from Israel, generating 1.13 million EUR last year and 304.35K EUR the year prior. The information is presented within the financial overview section of TradingView.
